Read our news
Amplitude Surgical announces its initial public offering on the regulated market of Euronext Paris.
AMPLITUDE today announced a definitive agreement under which AMPLITUDE Australia Pty Ltd, its Australian subsidiary, will acquire AUSTOFIX’s Orthopaedic Reconstruction business (Recon business)...
AMPLIFIX® 3 and AMPLIFIX® 3 with Gentamicin surgical cement are used to anchor orthopaedic implants during hip arthroplastyRead More
Double-digit growth, on average, since 1997
Average annual growth over the 2005–2015 period
Amplitude has undergone steady profitable growth since being formed in 1997. This performance makes it possible to invest in both a solid innovation policy and expanding sales in France and through the world.Read More
Amplitude's Management Board includes all the company’s business, marketing and support departments. Consisting of 12 managers, the Board meets regularly to analyse business performance and to identify areas of growth.Read More